Department of Medicine McMaster University Hamilton Canada.
Population Health Research Institute McMaster University and Hamilton Health Sciences Hamilton Canada.
J Am Heart Assoc. 2020 Feb 4;9(3):e014686. doi: 10.1161/JAHA.119.014686. Epub 2020 Jan 28.
Background Frailty is associated with higher mortality in individuals at high cardiovascular disease (CVD) risk. We hypothesize that frailty is a more important prognostic factor than CVD risk factors and aim to determine the prognostic value of a cumulative deficit frailty index in patients with or at high risk for CVD. Methods and Results We conducted an individual-level pooled analysis of participants with or at risk for CVD, recruited in 14 multicenter clinical trials. The cumulative deficit index was calculated as the proportion of 26 deficits exhibited. Individuals were categorized as nonfrail, prefrail, or frail if they had indexes of ≤0.1, >0.1 to 0.21, or >0.21, respectively. CVD risk was assessed using the Framingham score. Outcomes included CVD event (new or recurrent myocardial infarction, stroke, or heart failure) and mortality. We studied 154 696 patients (mean age, 70.8 years; 63% men) with median follow-up of 3.2 years. There were 17 535 CVD events and 15 067 deaths. The frail group (n=13 872) had higher risk of a CVD event (incidence rate ratio, 1.97; 95% CI, 1.85-2.08), all-cause mortality (hazard ratio, 1.91; 95% CI, 1.79-2.03), and CVD mortality (hazard ratio, 1.91; 95% CI, 1.77-2.05) than the nonfrail group (n=101 343). Associations remained unchanged after adjusting for CVD risk factors. The index statistically outperformed the Framingham score in its ability to discriminate CVD events (C-statistic, 0.60 [95% CI, 0.60-0.61] versus 0.58 [95% CI, 0.57-0.58], respectively; <0.001). Conclusions In individuals with or at high risk of developing CVD, the cumulative deficit index is associated with increased CVD events and mortality, independent of CVD risk factors, and adds incremental prognostic value.
衰弱与心血管疾病(CVD)高危人群的死亡率升高有关。我们假设衰弱是比 CVD 危险因素更重要的预后因素,并旨在确定累积缺陷衰弱指数在患有 CVD 或有 CVD 风险的患者中的预后价值。
我们对患有 CVD 或有 CVD 风险的参与者进行了一项个体水平的汇总分析,这些参与者是在 14 项多中心临床试验中招募的。累积缺陷指数的计算方法是表现出的 26 个缺陷的比例。如果指数≤0.1、>0.1 至 0.21 或>0.21,则将个体归类为非虚弱、虚弱前期或虚弱。使用 Framingham 评分评估 CVD 风险。结局包括 CVD 事件(新发或复发性心肌梗死、卒中和心力衰竭)和死亡率。我们研究了 154696 名患者(平均年龄 70.8 岁,63%为男性),中位随访时间为 3.2 年。发生 17535 例 CVD 事件和 15067 例死亡。虚弱组(n=13872)发生 CVD 事件的风险更高(发生率比,1.97;95%CI,1.85-2.08)、全因死亡率(风险比,1.91;95%CI,1.79-2.03)和 CVD 死亡率(风险比,1.91;95%CI,1.77-2.05)高于非虚弱组(n=101343)。调整 CVD 危险因素后,相关性仍然不变。该指数在区分 CVD 事件方面的能力优于 Framingham 评分(C 统计量,0.60[95%CI,0.60-0.61]与 0.58[95%CI,0.57-0.58];<0.001)。
在患有 CVD 或有 CVD 风险的人群中,累积缺陷指数与 CVD 事件和死亡率的增加相关,独立于 CVD 危险因素,并增加了额外的预后价值。